Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis.
Individuals with neurological diseases are at increased risk of fractures within 180 days of admission to long-term care in Ontario.
Late-onset multiple sclerosis presenting with cognitive dysfunction and severe cortical/infratentorial atrophy.
White matter disease: Longest follow-up of rituximab for neuromyelitis optica.
A profile of childhood neuropathies at a university hospital in Oman.
Cognition in MS correlates with resting-state oscillatory brain activity: An explorative MEG source-space study.
Oxidative modification of blood serum proteins in multiple sclerosis after interferon or mitoxantrone treatment.
Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination.
Gelsolin decreases actin toxicity and inflammation in murine multiple sclerosis.
RANTES correlates with inflammatory activity and synaptic excitability in multiple sclerosis.
Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation.
Oligodendroglial Argonaute protein Ago2 associates with molecules of the Mbp mRNA localization machinery and is a downstream target of Fyn kinase.
Development of a neuroprotective peptide that preserves survival pathways by preventing Kidins220/ARMS calpain processing induced by excitotoxicity.
Placebo controlled trials in neuromyelitis optica are needed and ethical.
The poor recovery of neuromyelitis optica spectrum disorder is associated with a lower level of CXCL12 in the human brain.
Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: A Diagnostic and Volumetric Validation Study.
Demographic and clinical profile of myelopathy patients.
IFN-γ-induced apoptosis of human embryonic stem cell derived oligodendrocyte progenitor cells is restricted by CXCR2 signaling.
Exacerbation of Experimental Autoimmune Encephalomyelitis in the Absence of Breast Regression Protein 39/Chitinase 3-Like 1.
Attention-Deficit/Hyperactivity Disorder in Offspring of Mothers With Inflammatory and Immune System Diseases.
Physical rehabilitation interventions in nonambulatory people with multiple sclerosis: a systematic review.
Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?
B cells in MS and NMO: pathogenesis and therapy.
Month of birth is not a definite risk factor for multiple sclerosis.
Pages
« first
‹ previous
…
532
533
534
535
536
537
538
539
540
…
next ›
last »